<DOC>
	<DOCNO>NCT01651585</DOCNO>
	<brief_summary>The infection cytomegalovirus ( CMV ) first cause congenital neurological handicap infectious origin . It probable néonatale viral load correlate become infect new-born baby . Among active antiviral treatment CMV , valacyclovir whose fœtal maternal tolerance evaluate pregnancy . Its harmlessness aptitude decrease CMV viral load justify evaluate study . Decrease fœtal viral load could make possible decrease symptomatology néonatale group infect fœtuses .</brief_summary>
	<brief_title>In Utero Treatment Cytomegalovirus congénitale Infection With Valacyclovir</brief_title>
	<detailed_description>The infection cytomegalovirus ( CMV ) first cause congenital neurological handicap infectious origin . It probable néonatale viral load correlate become infect new-born baby . Among active antiviral treatment CMV , valacyclovir whose fœtal maternal tolerance evaluate pregnancy . Its harmlessness aptitude decrease CMV viral load justify evaluate study . Decrease fœtal viral load could make possible decrease symptomatology néonatale infected fœtuses . To evaluate effect treatment valacyclovir inject per bone mother case prove fœtal infection CMV ( positive PCR CMV amniotic liquid ) present cerebral extra echographic sign able allotted infection . The main objective observe reduction number unfavourable exit ( symptomatic child birth ) reduction number medical interruption pregnancy practise fœtal anomaly . The secondary objective reduction CMV viral load blood cord take birth . The patient include treat . The observance evaluate . Taking consideration preliminary study , difference 20 % 2 group discount . The number calculated subject include test order guarantee power 80 % 43 . Recruitment carry multicentric way . The necessary duration inclusion 36 month The comparison two treatment carry composite principal criterion accord : proportion pregnancy unfavourable exit ( symptomatic child birth medical interruption pregnancy practise appeared cerebral echographic anomaly connection fœtal infection CMV ) . The secondary criterion judgement : viral load blood cord newborns infect utero CMV , compliance criterion tolerance .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Inclusion criterion : Age ≥ 18 year , Fœtal Infection CMV authenticate positivity research viral genome PCR amniotic liquid , Echographic Assessment reveal least one cerebral extra anomaly able connection infection CMV , And/or one isolate cerebral anomaly : Ventriculomégalie measure ventricular crossroad &lt; 15mm Signs lenticulostriated vasculopathy Intraparenchymateuses calcification Intraventricular adherence And/or biological sign generilazed infection CMV : fetal viremia &gt; 3000 copies/ml platelet &lt; 100 000/cc Absence request termination pregnancy start , Acceptance strict followup Multifield Center Prenatal diagnosis optimal observance found treatment , Collection write assent take part test . Affiliation mode social security equivalent . Exclusion criterion : Not affiliation mode social security ( profit right ) Patient le 18 year , Patient present another pathology obstetrical medical ( particular hepatic renal ) preexistent track contraindicate use valacyclovir , Patientes whose fœtus present echographic sign able connection infection CMV , Patientes whose fœtus present least one cerebral echographic anomaly : Ventriculomégalie measure ventricular crossroad ≥ 15mm Hyperechogenicity periventriculaire Hydrocephaly Microcephaly Increase cut large retrocérébelleuse cistern Hypoplasy vermienne Porencephaly Lissencephaly Cysts périventriculaires Hypoplasy callous body Patient active antiviral treatment CMV , Patient take part another therapeutic test , Patient refuse sign enlighten assent , Patient formulate request medical interruption pregnancy inclusion .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>viral disease</keyword>
	<keyword>cytomegalovirus infection</keyword>
	<keyword>first cause</keyword>
	<keyword>congenital</keyword>
	<keyword>neurological handicap</keyword>
	<keyword>infectious origin .</keyword>
</DOC>